Filter your search
- $3,600.00 – $7,200.00This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular […]January 22, 2021$3,600.00 – $7,200.00In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of the both the existing number of procedures for […]January 19, 2021$3,600.00 – $7,200.00Genetic involvement in the pathogenesis of neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases. Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes […]January 4, 2021$4,950.00 – $9,900.00The study of individual cells has long been an important part of biological research. Historically this has been a very manual process; some automated technologies are available. The need for microscopy and other traditional methods has remained, as new methods have also arrived, all of which have been gradually improved. The ability to amplify DNA […]December 23, 2020$4,000.00 – $8,000.00Vaccine Market Tops 37 Billion, Says Kalorama Information Report In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information’s report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025. THE MOST CURRENT VACCINE MARKET […]November 4, 2020$4,000.00 – $8,000.00COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis […]November 2, 2020$3,000.00 – $6,000.00The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently. In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths. Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals. This report provides comprehensive […]October 26, 2020$5,500.00 – $11,000.00Laboratory developed tests (LDTs) are not a new or recent phenomenon but due to the incredible need for testing of SARS-CoV-2, there has been a flood of new tests and the regulatory guidance has changed dramatically. Historically, these tests were called “home-brew tests” or “in-house tests.” Also, historically, these tests were low-volume, simple and well […]September 24, 2020$5,500.00 – $11,000.00What is the Market for Urgent Care Centers? What Services are they Selling? Who is Selling Testing and Vaccine Products to Urgent Care? Kalorama’s comprehensive report answers these questions, and more. With approximately 10,000 locations across the country, urgent care clinics (UCCs), are an increasingly important of the U.S. health care marketplace. They offer walk-in […]September 18, 2020$5,500.00 – $11,000.00The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of […]August 24, 2020